CARE Ratings Limited (CARERATING.NS)
INR 1237.0
(2.3%)
INR 1237.0
(2.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.31 Billion | 2.78 Billion | 2.46 Billion | 2.39 Billion | 2.43 Billion | 3.18 Billion |
| Cost of Revenue | 2.3 Billion | 1.33 Billion | 1.12 Billion | 1.07 Billion | 960.9 Million | 855.27 Million |
| Gross Profit | 1.01 Billion | 1.45 Billion | 1.34 Billion | 1.31 Billion | 1.47 Billion | 2.33 Billion |
| Operating Expenses | 79.55 Million | 505.31 Million | 622.54 Million | 387.39 Million | 713.77 Million | 607.5 Million |
| Selling, General and Administrative Expenses | 153.96 Million | 118.06 Million | 113.35 Million | 113.63 Million | 161.29 Million | 132.11 Million |
| Research and Development Expenses | 79.55 Million | 84.58 Million | 77.56 Million | 43.65 Million | - | - |
| Other Expenses | - | 379.36 Million | 11.19 Million | 14.51 Million | 10.49 Million | 10.77 Million |
| Cost and Expenses | 1.72 Billion | 1.84 Billion | 1.74 Billion | 1.46 Billion | 1.67 Billion | 1.46 Billion |
| Operating Income | 1.59 Billion | 945.17 Million | 721.15 Million | 879.7 Million | 735.52 Million | 1.71 Billion |
| Interest Expense | 17.12 Million | 10.01 Million | 4.63 Million | 6.17 Million | 9.27 Million | - |
| Income Tax Expense | 440.65 Million | 402.88 Million | 218.01 Million | 276.81 Million | 206.13 Million | 636.59 Million |
| Earnings before Tax | 1.46 Billion | 1.25 Billion | 986.3 Million | 1.18 Billion | 1.04 Billion | 2.01 Billion |
| Net Income | 1 Billion | 835.29 Million | 751.07 Million | 895.15 Million | 823.7 Million | 1.37 Billion |
| Earnings Per Share Basic | 33.77 | 28.17 | 25.45 | 30.38 | 27.96 | 46.66 |
| Earnings Per Share Diluted | 33.67 | 28.17 | 25.31 | 30.33 | 27.96 | 46.66 |
| Weighted Average Shares Outstanding | 29.76 Million | 29.65 Million | 29.51 Million | 29.46 Million | 29.46 Million | 29.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.85 Million | 29.65 Million | 29.67 Million | 29.51 Million | 29.46 Million | 29.46 Million |
| Gross Margin | 0.31 | 0.52 | 0.55 | 0.55 | 0.61 | 0.73 |
| EBIT Margin | 0.34 | 0.51 | 0.43 | 0.50 | 0.40 | 0.51 |
| Profit Margin | 0.30 | 0.30 | 0.30 | 0.37 | 0.34 | 0.43 |
| EBITDA | 1.12 Billion | 1.37 Billion | 1.06 Billion | 1.27 Billion | 1.12 Billion | 1.62 Billion |
| Earnings Before Tax Margin | 0.48 | 0.34 | 0.29 | 0.37 | 0.30 | 0.54 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.17 Billion | 789.2 Million | 901.48 Million | 3.31 Billion | 786.76 Million | 964.41 Million |
| Cost of Revenue | 457.31 Million | 599.01 Million | 637.87 Million | 2.3 Billion | 425.06 Million | 404.55 Million |
| Gross Profit | 716.36 Million | 190.18 Million | 263.6 Million | 1.01 Billion | 361.7 Million | 559.86 Million |
| Operating Expenses | 187.7 Million | 141.59 Million | 205.47 Million | 654.5 Million | 154.2 Million | 167.06 Million |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | 79.55 Million | - | - | - |
| Other Expenses | 187.7 Million | 118.7 Million | 102.87 Million | 466.9 Million | 136.82 Million | 111.86 Million |
| Cost and Expenses | 645.01 Million | 599.01 Million | 637.87 Million | 2.3 Billion | 579.26 Million | 571.61 Million |
| Operating Income | 528.66 Million | 190.18 Million | 263.6 Million | 1.01 Billion | 344.32 Million | 504.66 Million |
| Interest Expense | 4.92 Million | 4.62 Million | 4.56 Million | 17.12 Million | 4.68 Million | 4.06 Million |
| Income Tax Expense | 173.53 Million | 90.44 Million | 116.41 Million | 440.65 Million | 100.39 Million | 143.26 Million |
| Earnings before Tax | 642.32 Million | 304.26 Million | 361.91 Million | 1.46 Billion | 339.63 Million | 500.6 Million |
| Net Income | 460.89 Million | 207.34 Million | 240.84 Million | 1 Billion | 234.55 Million | 351.74 Million |
| Earnings Per Share Basic | 15.41 | 6.94 | 8.07 | - | 7.88 | 11.83 |
| Earnings Per Share Diluted | 15.36 | 6.91 | 8.03 | - | 7.85 | 11.79 |
| Weighted Average Shares Outstanding | 29.9 Million | 29.87 Million | 29.99 Million | 29.85 Million | 29.77 Million | 29.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 30 Million | 30 Million | 29.99 Million | 29.85 Million | 29.88 Million | 29.83 Million |
| Gross Margin | 0.61 | 0.24 | 0.29 | 0.31 | 0.46 | 0.58 |
| EBIT Margin | 0.58 | 0.28 | 0.32 | - | 0.47 | 0.55 |
| Profit Margin | 0.39 | 0.26 | 0.27 | 0.30 | 0.30 | 0.36 |
| EBITDA | 675.79 Million | 218.22 Million | 290.33 Million | - | 370.37 Million | 530.98 Million |
| Earnings Before Tax Margin | 0.45 | 0.24 | 0.29 | 0.31 | 0.44 | 0.52 |
LYPSAGEMS
VRN
NESR
0NLY
FNV
NTCPF